Related references
Note: Only part of the references are listed.Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy
Brahmanaidu Parim et al.
HEART FAILURE REVIEWS (2019)
Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting
Adam J. Wilson et al.
HEART (2018)
Baicalin inhibits pressure overload -induced cardiac fibrosis through regulating AMPK/TGF-P/Smads signaling pathway
Yichuan Xiao et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2018)
Abnormal Myocardial Dietary Fatty Acid Metabolism and Diabetic Cardiomyopathy
Andre C. Carpentier
CANADIAN JOURNAL OF CARDIOLOGY (2018)
Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial
Yuanxing Hang et al.
LIPIDS IN HEALTH AND DISEASE (2018)
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Antonio Cuadrado et al.
PHARMACOLOGICAL REVIEWS (2018)
Baicalin administration attenuates hyperglycemia-induced malformation of cardiovascular system
Guang Wang et al.
CELL DEATH & DISEASE (2018)
Baicalin induces cellular senescence in human colon cancer cells via upregulation of DEPP and the activation of Ras/Raf/MEK/ERK signaling
Zhou Wang et al.
CELL DEATH & DISEASE (2018)
Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart
Hong Yang et al.
CELL DEATH & DISEASE (2018)
Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ss/Fyn pathway
Ying Xin et al.
REDOX BIOLOGY (2018)
Melatonin improves cardiac function in a mouse model of heart failure with preserved ejection fraction
Yuan Liu et al.
REDOX BIOLOGY (2018)
Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Aidin Rawshani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Baicalin provides neuroprotection in traumatic brain injury mice model through Akt/Nrf2 pathway
Jiang Fang et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Baicalin attenuates in vivo and in vitro hyperglycemia-exacerbated ischemia/reperfusion injury by regulating mitochondrial function in a manner dependent on AMPK
Shanshan Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1
Hai-han Liao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Baicalin Ameliorates Liver Injury Induced by Chronic plus Binge Ethanol Feeding by Modulating Oxidative Stress and Inflammation via CYP2E1 and NRF2 in Mice
Ping He et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Protective effect of butin against ischemia/reperfusion-induced myocardial injury in diabetic mice: involvement of the AMPK/GSK-3β/Nrf2 signaling pathway
Jialin Duan et al.
SCIENTIFIC REPORTS (2017)
Baicalin Attenuates Cardiac Dysfunction and Myocardial Remodeling in a Chronic Pressure-Overload Mice Model
Yanqing Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Lipid metabolism and signaling in cardiac lipotoxicity
Kenneth D'Souza et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
Novel protective mechanism of reducing renal cell damage in diabetes: Activation AMPK by AICAR increased NRF2/OGG1 proteins and reduced oxidative DNA damage
Samy L. Habib et al.
CELL CYCLE (2016)
Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice
Yuan Yuan et al.
HYPERTENSION (2016)
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants
Bin Zhou et al.
LANCET (2016)
AMPK Facilitates Nuclear Accumulation of Nrf2 by Phosphorylating at Serine 550
Min Sung Joo et al.
MOLECULAR AND CELLULAR BIOLOGY (2016)
Is AMPK the savior of the failing heart?
Ty T. Kim et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway
Zhiguo Zhang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Diabetic Cardiomyopathy and Its Prevention by Nrf2: Current Status
Jing Chen et al.
DIABETES & METABOLISM JOURNAL (2014)
Diabetic Downregulation of Nrf2 Activity via ERK Contributes to Oxidative Stress-Induced Insulin Resistance in Cardiac Cells In Vitro and In Vivo
Yi Tan et al.
DIABETES (2011)
Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy
Mohanraj Rajesh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Resveratrol Prevents the Prohypertrophic Effects of Oxidative Stress on LKB1
Vernon W. Dolinsky et al.
CIRCULATION (2009)
The PPAR alpha-PGC-1 alpha Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium
Jennifer G. Duncan et al.
PPAR RESEARCH (2008)
Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin
Shunsuke Tanigawa et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane
F Hong et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2005)
4-Hydroxy-2-nonenal: a product and mediator of oxidative stress
K Uchida
PROGRESS IN LIPID RESEARCH (2003)
Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress
DD Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Share Paper
